Fabbi Manrica, Milani Marika Sharmayne, Giacopuzzi Simone, De Werra Carlo, Roviello Franco, Santangelo Claudia, Galli Federica, Benevento Angelo, Rausei Stefano
Department of General Surgery, Cittiglio-Angera Hospital, ASST Settelaghi, 21033 Varese, Italy.
General and Upper GI Surgery Division, Department of Surgery, University of Verona, 37134 Verona, Italy.
J Clin Med. 2024 Jul 20;13(14):4240. doi: 10.3390/jcm13144240.
: Despite the strong declining trends in incidence and mortality over the last decades, gastric cancer (GC) is still burdened with high mortality, even in high-income countries. To improve GC prognosis, several guidelines have been increasingly published with indications about the most appropriate GC management. The Italian Society of Digestive System Pathology (SIPAD) and Gastric Cancer Italian Research Group (GIRCG) designed a survey for both surgeons and patients with the purpose of evaluating the degree of application and adherence to guidelines in GC management in Italy. : Between January and May 2022, a questionnaire has been administered to a sample of Italian surgeons and, in a simplified version, to members of the Patient Association "Vivere Senza Stomaco" (patients surgically treated for GC between 2008 and 2021) to investigate the diagnosis, staging, and treatment issues. : The survey has been completed by 125 surgeons and 125 patients. Abdominal CT with gastric hydro-distension before treatment was not widespread in both groups (47% and 42%, respectively). The rate of surgeons stating that they do not usually perform minimally invasive gastrectomy was 15%, but the rate of patients who underwent a minimally invasive approach was 22% (between 2011 and 2022). The percentage of surgeons declaring to perform extended lymphadenectomy (>D2) was 97%, although a limited lymph node dissection rate was observed in about 35% of patients. : This survey shows several important discrepancies from surgical attitudes declared by surgeons and real data derived from the reports available to the patients, suggesting heterogeneous management in clinical practice and, thus, a not rigorous adherence to the guidelines.
尽管在过去几十年中胃癌(GC)的发病率和死亡率呈显著下降趋势,但即使在高收入国家,胃癌的死亡率仍然很高。为了改善胃癌的预后,越来越多的指南相继发布,其中给出了最合适的胃癌管理建议。意大利消化系统病理学会(SIPAD)和意大利胃癌研究组(GIRCG)针对外科医生和患者开展了一项调查,旨在评估意大利在胃癌管理中对指南的应用程度和遵循情况。2022年1月至5月期间,向一组意大利外科医生发放了问卷,并以简化版问卷向“无胃生存”患者协会的成员(2008年至2021年间接受过胃癌手术治疗的患者)进行了调查,以研究诊断、分期和治疗方面的问题。125名外科医生和125名患者完成了该调查。两组中治疗前进行胃水扩张的腹部CT检查均未广泛开展(分别为47%和42%)。表示通常不进行微创胃切除术的外科医生比例为15%,但接受微创治疗的患者比例为22%(2011年至2022年期间)。宣称进行扩大淋巴结清扫术(>D2)的外科医生比例为97%,尽管约35%的患者观察到淋巴结清扫范围有限。这项调查显示,外科医生宣称的手术态度与患者报告中的实际数据存在一些重要差异,这表明临床实践中的管理存在异质性,因此对指南的遵循并不严格。